BGPT: Paper Review: Bacterial Sliding Clamp Inhibitors that Mimic the Sequential Binding Mechanism of Endogenous Linear Motifs

Explore by Goal

Quick Explanation Copied

This well-executed medicinal chemistry study reports tetrahydrocarbazole (THC) inhibitors of the E. coli DNA sliding clamp that mimic the sequential

Long Explanation

What the Paper Actually Shows

The authors report structure-guided development of tetrahydrocarbazole (THC)-based inhibitors targeting the protein-protein interaction between the E. coli DNA sliding clamp (SC) and linear motifs (LMs) from DNA polymerases. Their previously published

Feedback:

Updated: October 03, 2026

BGPT Paper Review

Study Novelty

80%

Discovery of a ligand-induced allosteric pocket (subsite III) via a 10 Å loop rearrangement in a well-studied PPI target is genuinely novel. The sequential-mimic inhibitor design strategy is also creative and underexplored.

Scientific Quality

80%

Multiple orthogonal methods (FP, ITC, crystallography, in vitro replication) validate findings; PDB structures deposited; ITC matches Ki. Limitations: no in vivo or bacterial MIC data, no selectivity panel vs. human PCNA, weak lead potencies (11–17 µM), no cell permeability data.

Study Generality

70%

The sequential anchor-based inhibitor design strategy generalizes to other LM-mediated PPI systems and is applicable across Gram-negative SCs (subsite III loop conserved), but specific compounds are limited to E. coli SC.

Study Usefulness

70%

Provides a validated structural scaffold and strategy for PPI inhibitor design against a novel antibiotic target; six PDB structures deposited. Limited by moderate potency and absent whole-cell data.

Study Reproducibility

80%

Full synthetic procedures, assay conditions, crystallographic statistics, and PDB codes provided; methods and buffer compositions detailed. Reproducibility hampered by small synthetic yields (4-6%) and reliance on specialized protein purification.

Explanatory Depth

80%

Deep mechanistic insight from sequential crystallographic snapshots showing M362 gating, G174 H-bond formation, and allosteric loop rearrangement; thermodynamic analysis links structure to binding energetics.

🎁 Authors: Collect 401 Free Science Tokens (≈ $40.1 USD)

Claim My Author Tokens

Use for 100 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $40.1 USD)

Top Data Sources Export MCP

1. Bacterial Sliding Clamp Inhibitors that Mimic the Sequential Binding Mechanism of Endogenous Linear Motifs [2015]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. Translational readthrough extensions in Drosophila melanogaster are long, disordered C-termini enriched in low-complexity regions and interaction motifs, paralleling alternative splicing, whereas Saccharomyces cerevisiae TR extensions are short, structured, and Pfam-free, suggesting species-specific functional roles and limited cross-species conservation. [2016]

7QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. This study engineeringly produced a soluble, monomeric form of human monoglyceride lipase (MGL), solved a 1.35 Å crystal structure of MGL bound to a reversible inhibitor revealing a novel closed lid-domain conformation, and proposed a catalytic-cycle model in which MGL may detach from membranes during turnover, with implications for inhibitor design and protein solubility strategies. [2011]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. CLARE is a web-based computational method that learns a tissue-specific sequence code from known regulatory elements to predict new regulatory regions and identify likely transcription factor binding motifs. [2011]

7QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

5. This review discusses the latest strategies and advancements in targeting protein-protein interactions (PPIs) with small-molecule inhibitors, highlighting the importance of 'hot spots' in PPI interfaces and various screening and design methodologies for drug discovery. [2015]

8QualityResults Limitations Context Blindspots Methods

↗ Paper Review ↗ Full Paper

Key Insight

The discovery that a small molecule can allosterically remodel a protein surface via residue-pair switching (Q149-D150 and R152-Y153) to create a previously unobserved

Keep Exploring

Would 5m's allosteric subsite III pocket formation be thermodynamically favored at physiological temperatures or is it a crystallization artifact?

Could sequential anchor-based inhibitor design be applied to targeting human PCNA in oncology drug discovery, given its analogous linear motif recognition?

Hypothesis Graveyard

That SC inhibitor binding can be predicted from subsite I occupancy alone—falsified by 5m's subsite III formation, which shows ligand-specific allostery that static anchor-binding models miss.

That potency improvements should correlate with additional hydrogen bonds—contradicted by 5m achieving comparable affinity to 5b despite lacking the G174 H-bond and R152/H175 contacts.

Potential Experiments

Test whether 5m inhibits SC-DNA interaction by performing a fluorescence anisotropy DNA-binding assay with and without 5m, using the V151 displacement into the dsDNA channel as a structural rationale.

Soak 5m into crystals of a Gram-positive SC (e.g., S. aureus SC) to directly test whether the subsite III loop rearrangement is absent, as predicted by lower sequence conservation of switching residues.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I am biased toward positive evaluation of crystallography-backed medicinal chemistry papers, potentially underweighting translational limitations.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

What the Paper Actually Shows

BGPT Paper Review

Study Novelty

Discovery of a ligand-induced allosteric pocket (subsite III) via a 10 Å loop rearrangement in a well-studied PPI target is genuinely novel. The sequential-mimic inhibitor design strategy is also creative and underexplored.

Scientific Quality

Multiple orthogonal methods (FP, ITC, crystallography, in vitro replication) validate findings; PDB structures deposited; ITC matches Ki. Limitations: no in vivo or bacterial MIC data, no selectivity panel vs. human PCNA, weak lead potencies (11–17 µM), no cell permeability data.

Study Generality

The sequential anchor-based inhibitor design strategy generalizes to other LM-mediated PPI systems and is applicable across Gram-negative SCs (subsite III loop conserved), but specific compounds are limited to E. coli SC.

Study Usefulness

Provides a validated structural scaffold and strategy for PPI inhibitor design against a novel antibiotic target; six PDB structures deposited. Limited by moderate potency and absent whole-cell data.

Study Reproducibility

Full synthetic procedures, assay conditions, crystallographic statistics, and PDB codes provided; methods and buffer compositions detailed. Reproducibility hampered by small synthetic yields (4-6%) and reliance on specialized protein purification.

Explanatory Depth

Deep mechanistic insight from sequential crystallographic snapshots showing M362 gating, G174 H-bond formation, and allosteric loop rearrangement; thermodynamic analysis links structure to binding energetics.

Top Data Sources ExportMCP

1. Bacterial Sliding Clamp Inhibitors that Mimic the Sequential Binding Mechanism of Endogenous Linear Motifs [2015]

4. CLARE is a web-based computational method that learns a tissue-specific sequence code from known regulatory elements to predict new regulatory regions and identify likely transcription factor binding motifs. [2011]

5. This review discusses the latest strategies and advancements in targeting protein-protein interactions (PPIs) with small-molecule inhibitors, highlighting the importance of 'hot spots' in PPI interfaces and various screening and design methodologies for drug discovery. [2015]

6. This study explores the challenges and strategies in designing small-molecule inhibitors targeting protein-protein interactions, particularly focusing on the p53-hdm2 interaction as a case study for drug discovery. [2006]

8. A comprehensive review of PROTACs as an innovative strategy for targeted protein degradation, detailing mechanisms, ligases, design principles, clinical progress, advantages over traditional inhibitors, and remaining challenges. [2024]

9. Rosetta-based design of oxopiperazine topographical helix mimics using noncanonical residues yields potent nanomolar inhibitors of p53–MDM2 and HIF1α–p300/CBP PPIs, demonstrating a general strategy to create helix-mimetic inhibitors of protein–protein interactions. [2014]

10. Structure- and mechanism-based drug design strategies are highlighted as effective routes to novel, selective inhibitors of oncogenic protein kinases and to address resistance, with examples like Imatinib and EGFR inhibitors. [2004]

11. Peptide blockers of signalosome assembly can disrupt intracellular signaling by mimicking protein-interaction surfaces, with evidence across in vitro and in vivo TLR pathways and a discussion of design strategies and remaining challenges. [2024]

16. This study investigates a series of compounds designed to bind to the S2-S3 pockets of thrombin, revealing significant increases in binding affinity through specific structural modifications and hydrogen bonding interactions. [2009]

18. Binding Inhibitors of the Bacterial Sliding Clamp by Design [2011]

20. Comprehensive review of computational and experimental strategies targeting CHIKV, summarizing viral protein targets and reported inhibitors to guide antiviral development. [2021]

22. This narrative review surveys inhibitors of proteins that recognize phosphotyrosine, including protein tyrosine phosphatases, SH2 domains, and Cdc25, emphasizing pTyr mimetics, structural studies, and design strategies. [2004]

Ask a Follow-Up

Key Insight

The discovery that a small molecule can allosterically remodel a protein surface via residue-pair switching (Q149-D150 and R152-Y153) to create a previously unobserved

Keep Exploring

Would 5m's allosteric subsite III pocket formation be thermodynamically favored at physiological temperatures or is it a crystallization artifact?

Could sequential anchor-based inhibitor design be applied to targeting human PCNA in oncology drug discovery, given its analogous linear motif recognition?

Hypothesis Graveyard

That SC inhibitor binding can be predicted from subsite I occupancy alone—falsified by 5m's subsite III formation, which shows ligand-specific allostery that static anchor-binding models miss.

That potency improvements should correlate with additional hydrogen bonds—contradicted by 5m achieving comparable affinity to 5b despite lacking the G174 H-bond and R152/H175 contacts.

Potential Experiments

Test whether 5m inhibits SC-DNA interaction by performing a fluorescence anisotropy DNA-binding assay with and without 5m, using the V151 displacement into the dsDNA channel as a structural rationale.

Soak 5m into crystals of a Gram-positive SC (e.g., S. aureus SC) to directly test whether the subsite III loop rearrangement is absent, as predicted by lower sequence conservation of switching residues.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I am biased toward positive evaluation of crystallography-backed medicinal chemistry papers, potentially underweighting translational limitations.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP